An Experimental Study of the Effects of Patient Race, Sexual Orientation, and Injection Drug Use on Providers’ PrEP-Related Clinical Judgments
Sarah K. Calabrese(Yale University), John F. Dovidio(University of Connecticut), Kenneth H. Mayer(Miriam Hospital), E. Jennifer Edelman(Yale University), Samuel R. Bunting(University of Chicago), Nathan B. Hansen(University of Georgia), Ana María del Río‐González(Milken Institute), Manya Magnus(Milken Institute), Douglas Krakower, Joshua G. Rosenberger(Pennsylvania State University), David A. Kalwicz(George Washington University), Djordje Modrakovic(George Washington University), Valerie A. Earnshaw(University of Delaware), Trace Kershaw(Department of Health)
Cited by 28
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial
|The Lancet Infectious Diseases|2014|513
Emergence of Multidrug-Resistant, Community-Associated, Methicillin-Resistant <i>Staphylococcus aureus</i> Clone USA300 in Men Who Have Sex with Men
|Annals of Internal Medicine|2008|391